|
1
|
Cancer Information Service, National
Cancer Center, . Cancer mortality from Vital Statistics in Japan
(1958–2016). http://ganjoho.jp/en/professional/statistics/table_download.html
|
|
2
|
Vinogradov S and Wei X: Cancer stem cells
and drug resistance: The potential of nanomedicine. Nanomedicine
(Lond). 7:597–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abdullah LN and Chow EK: Mechanisms of
chemoresistance in cancer stem cells. Clin Transl Med. 2:32013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Colak S and Medema JP: Cancer stem
cells-important players in tumor therapy resistance. FEBS J.
281:4779–4791. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dawood S, Austin L and Cristofanilli M:
Cancer stem cells: Implications for cancer therapy. Oncology
(Williston Park). 28:1101–1107, 1110. 2014.PubMed/NCBI
|
|
6
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abel EV, Kim EJ, Wu J, Hynes M, Bednar F,
Proctor E, Wang L, Dziubinski ML and Simeone DM: The Notch pathway
is important in maintaining the cancer stem cell population in
pancreatic cancer. PLoS One. 9:e919832014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang R, Wang G, Song Y, Tang Q, You Q,
Liu Z, Chen Y, Zhang Q, Li J, Li J, Muhammand S and Wang X:
Colorectal cancer stem cell and chemoresistant colorectal cancer
cell phenotypes and increased sensitivity to Notch pathway
inhibitor. Mol Med Rep. 12:2417–2424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee HW, Kim SJ, Choi IJ, Song J and Chun
KH: Targeting Notch signaling by γ-secretase inhibitor I enhances
the cytotoxic effect of 5-FU in gastric cancer. Clin Exp
Metastasis. 32:593–603. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katoh M: Dysregulation of stem cell
signaling network due to germline mutation, SNP, Helicobacter
pylori infection, epigenetic change and genetic alteration in
gastric cancer. Cancer Biol Ther. 6:832–839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Du X, Cheng Z, Wang YH, Guo ZH, Zhang SQ,
Hu JK and Zhou ZG: Role of Notch signaling pathway in gastric
cancer: A meta-analysis of the literature. World J Gastroenterol.
20:9191–9199. 2014.PubMed/NCBI
|
|
12
|
Zhang ZP, Sun YL, Fu L, Gu F, Zhang L and
Hao XS: Correlation of Notch1 expression and activation to
cisplatin-sensitivity of head and neck squamous cell carcinoma. Ai
Zheng. 28:100–103. 2009.PubMed/NCBI
|
|
13
|
Gu F, Ma Y, Zhang Z, Zhao J, Kobayashi H,
Zhang L and Fu L: Expression of Stat3 and Notch1 is associated with
cisplatin resistance in head and neck squamous cell carcinoma.
Oncol Rep. 23:671–676. 2010.PubMed/NCBI
|
|
14
|
Cui D, Dai J, Keller JM, Mizokami A, Xia S
and Keller ET: Notch pathway inhibition using PF-03084014, a
γ-secretase inhibitor (GSI), enhances the antitumor effect of
docetaxel in prostate cancer. Clin Cancer Res. 21:4619–4629. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Da Silva TG, Jin K, Han X,
Ranganathan P, Zhu X, Sanchez-Mejias A, Bai F, Li B, Fei DL, et al:
Notch signaling drives stemness and tumorigenicity of esophageal
adenocarcinoma. Cancer Res. 74:6364–6374. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu M, Peng Q, Jiang I, Carroll C, Han G,
Rymer I, Lippincott J, Zachwieja J, Gajiwala K, Kraynov E, et al:
Specific inhibition of Notch1 signaling enhances the antitumor
efficacy of chemotherapy in triple negative breast cancer through
reduction of cancer stem cells. Cancer Lett. 328:261–270. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ,
Shim HE, Yoon S, Baek SY, Kim BS, Kang CD and Oh SO: Cancer spheres
from gastric cancer patients provide an ideal model system for
cancer stem cell research. Cell Mol Life Sci. 68:3589–3605. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen T, Yang K, Yu J, Meng W, Yuan D, Bi
F, Liu F, Liu J, Dai B, Chen X, et al: Identification and expansion
of cancer stem cells in tumor tissues and peripheral blood derived
from gastric adenocarcinoma patients. Cell Res. 22:248–258. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang J, Zhang Y, Chuai S, Wang Z, Zheng
D, Xu F, Zhang Y, Li C, Liang Y and Chen Z: Trastuzumab (herceptin)
targets gastric cancer stem cells characterized by CD90 phenotype.
Oncogene. 31:671–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu G, Shen J, Ou Yang X, Sasahara M and Su
X: Cancer stem cells: The ‘heartbeat’ of gastric cancer. J
Gastroenterol. 48:781–797. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li LC, Wang DL, Wu YZ, Nian WQ, Wu ZJ, Li
Y, Ma HW and Shao JH: Gastric tumor-initiating CD44+
cells and epithelial-mesenchymal transition are inhibited by
γ-secretase inhibitor DAPT. Oncol Lett. 10:3293–3299. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z and Liu C: Lgr5-positive cells are
cancer-stem-cell-like cells in gastric cancer. Cell Physiol
Biochem. 36:2447–2455. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang L, Guo X, Zhang D, Fan Y, Qin L,
Dong S and Zhang L: Upregulated miR-132 in Lgr5+ gastric
cancer stem cell-like cells contributes to cisplatin-resistance via
SIRT1/CREB/ABCG2 signaling pathway. Mol Carcinog. 56:2022–2034.
2017. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xi HQ, Cui JX, Shen WS, Wu XS, Bian SB, Li
JY, Song Z, Wei B and Chen L: Increased expression of Lgr5 is
associated with chemotherapy resistance in human gastric cancer.
Oncol Rep. 32:181–188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang HH, Lee H, Hu MK, Tsao PN, Juan HF,
Huang MC, Shih YY, Wang BJ, Jeng YM, Chang CL, et al: Notch1
expression predicts an unfavorable prognosis and serves as a
therapeutic target of patients with neuroblastoma. Clin Cancer Res.
16:4411–4420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li XB, Yang G, Zhu L, Tang YL, Zhang C, Ju
Z, Yang X and Teng Y: Gastric Lgr5(+) stem cells are the cellular
origin of invasive intestinal-type gastric cancer in mice. Cell
Res. 26:838–849. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watanabe T, Okumura T, Hirano K, Yamaguchi
T, Sekine S, Nagata T and Tsukada K: Circulating tumor cells
expressing cancer stem cell marker CD44 as a diagnostic biomarker
in patients with gastric cancer. Oncol Lett. 13:281–288. 2017.
View Article : Google Scholar : PubMed/NCBI
|
